ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
PHASE-I TRIAL OF DOXORUBICIN WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG-RESISTANCE
Author(s): BARTLETT NL, LUM BL, FISHER GA, BROPHY NA, EHSAN MN, HALSEY J, SIKIC BI
Source: JOURNAL OF CLINICAL ONCOLOGY    Volume: 12    Issue: 4    Pages: 835-842    Published: APR 1994  
Times Cited: 140     References: 36     
Document Type: Article
Language: English
Addresses:
1. STANFORD UNIV, MED CTR, SCH MED, DEPT MED, DIV ONCOL, STANFORD, CA 94305 USA
2. STANFORD UNIV, SCH MED, DEPT MED, DIV CLIN PHARMACOL, STANFORD, CA 94305 USA
3. VET AFFAIRS MED CTR, PALO ALTO, CA 94304 USA
Publisher: W B SAUNDERS CO, INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399
Subject Category: Oncology
IDS Number: NG395
ISSN: 0732-183X
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo